Global Vasculitis Market Pipeline Research Report

Oct 08, 2015, 06:00 ET from Life Science Industry Research

PUNE, India, October 8, 2015 /PRNewswire/ --

New market research titled Vasculitis - Pipeline Review, H2 2015 is spread across 99 pages, analyzing 14 companies, 12 drug profiles and supported with 31 tables and 13 figures.

Complete report on Vasculitis market pipeline providing data and information that helps strengthen Vasculitis R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products is now available at .

This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies mentioned in this Vasculitis pipeline H2 2015 review report include AnGes MG, Inc., Aprogen, Inc., ChemoCentryx, Inc., Epirus Biopharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Hemostemix Ltd, K-Stemcell Co., Ltd., Panacea Biotec Limited, Pfizer Inc., Sandoz International GmbH, Stempeutics Research Private Limited, Teijin Pharma Limited and XOMA Corporation. Drug profiles discussed in this report are ACP-01, belimumab, beperminogene perplasmid, CCX-168, gevokizumab, immune globulin (human), Monoclonal Antibodies to Antagonize GPR4 for Vascular Inflammation, PF-1355, rituximab biosimilar, Stempeucel, tocilizumab and Vascostem.  Order a copy of Vasculitis - Pipeline Review, H2 2015 market research report at .

The report provides a snapshot of the global therapeutic landscape of Vasculitis and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Vasculitis and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects. A review of the Vasculitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources, pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Vasculitis pipeline on the basis of target, MoA, route of administration and molecule type, latest news and deals relating related to pipeline products.

Another newly published market research titled Thromboembolism - Pipeline Review, H2 2015 is a report that provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies and helps identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. The research helps develop strategic initiatives by understanding the focus areas of leading companies, identify and understand important and diverse types of therapeutics under development for thromboembolism as well as plan mergers and acquisitions effectively by identifying key players of the most promising pipeline. Devise corrective measures for pipeline projects by understanding thromboembolism pipeline depth and focus of Indication therapeutics as well as develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope with the help of this thromboembolism pipeline review report of 100 pages available at .

Explore more reports on Pharmaceuticals market at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441

Connect with Us:  

G+ / Google Plus:


RSS / Feeds:

SOURCE Life Science Industry Research